Fortrea selects Cognizant as its technology transformation provider. 

Cognizant (Nasdaq: CTSH) and Fortrea (Nasdaq: FTRE), a prominent provider of clinical development and patient access solutions in the life sciences sector, have announced a strategic partnership for technology transformation.

Cognizant (Nasdaq: CTSH) and Fortrea (Nasdaq: FTRE), a prominent provider of clinical development and patient access solutions in the life sciences sector, have announced a strategic partnership for technology transformation. Cognizant has been chosen as the technology transformation provider for Fortrea to enhance its digital infrastructure securely and efficiently.

Under the four-year agreement, Cognizant is set to revamp Fortrea’s global technology environment, focusing on the deployment of next-generation hybrid cloud and platforms to support digital innovation. The collaboration aims to empower Fortrea to become a “born digital” organization, fostering a seamless digital experience across various touchpoints.

Following its successful spin-off in June 2023, Fortrea is now geared towards capitalizing on growth opportunities in clinical trials and patient access. In 2024, Cognizant will play a key role in transitioning Fortrea from its former parent company’s service agreements, facilitating a smooth switch and establishing the global Fortrea infrastructure, application management, and end-user services.

Cognizant’s strategic services will enhance Fortrea’s data and analytical capabilities, setting new standards in the Contract Research Organization (CRO) industry. Leveraging Cognizant’s expertise in life sciences and healthcare technology, Fortrea aims to address the evolving needs of its customers and maintain its leading positions in oncology, clinical pharmacology, and partnership models.

Alejandro Martinez Galindo, Chief Information Officer of Fortrea, emphasized the organization’s renewed agility post-spin-off, stating that the strategic investment in technology will contribute to building a modern ecosystem designed to accelerate decision-making and innovation in clinical development.Cognizant’s EVP, Software and Platform Engineering, Prasad Sankaran, expressed pride in the partnership, highlighting the collaboration’s goal to fortify Fortrea’s position as a best-in-class digital Contract Research Organization. The EVP & President of the Americas at Cognizant, Surya Gummadi, anticipates the application of Cognizant’s expertise to support Fortrea’s digital experience goals and drive a shift towards a fully digital ecosystem for improved customer experiences and efficiency

Scroll to top Do NOT follow this link or you will be banned from the site!